NCT01256476

Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia

A RANDOMIZED, DOUBLE-BLIND, ACTIVE CONTROLLED, PARALLEL GROUP STUDY OF PITAVASTATIN 4 MG VS. PRAVASTATIN 40 MG IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 328 (actual)
• Sponsor: Kowa Research Institute, Inc. · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Randomized, double-blind, double-dummy, 12-week, active-controlled study of pitavastatin 4 mg daily(QD) vs. pravastatin 40 mg daily(QD) in subjects with primary hyperlipidemia or mixed dyslipidemia.

Conditions

• Primary Dyslipidemia
• Mixed Dyslipidemia

Interventions

Type	Name	Description
DRUG	pitavastatin	pitavastatin 4 mg once daily (QD)
DRUG	pravastatin	Pravastatin 40 mg once daily (QD)

Timeline

• Start date: 2010-10-01
• Primary completion: 2011-06-01
• Completion: 2011-06-01
• First posted: 2010-12-08
• Last updated: 2012-05-08
• Results posted: 2012-04-30

Locations

44 sites across 1 country: United States